Page 5 - மருந்து ஆம்ப் சாதனம் வளர்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்து ஆம்ப் சாதனம் வளர்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்து ஆம்ப் சாதனம் வளர்ச்சி Today - Breaking & Trending Today

Regeneron's COVID-19 cocktail helps prevent symptomatic disease: study

3 Min Read
ZURICH (Reuters) -Regeneron is pursuing U.S. approval for its COVID-19 monoclonal antibody cocktail as a preventative treatment after it helped cut the risk of symptomatic infections in households where someone else is ill, the U.S. drugmaker said on Monday.
FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company s Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid
REGEN-COV, a combination of casirivimab and imdevimab, protected household contacts from exposure to SARS-CoV-2, with 72% protection against symptomatic infections in the first week, and 93% after that, according to trial data released by the company. ....

United States , Caroline Copley , John Miller , Hugh Lawson , Thomson Reuters Trust Principles , University Of Pennsylvania , South San Francisco , Thomson Reuters Trust , Corona Virus , Bio Therapeutic Drugs Trbc Level 5 , Content Produced In Bangalore , Company News , Drug Amp Device Development , Health Medicine , Biotechnology Amp Medical Research Trbc Level 4 , Pharmaceuticals Nec Trbc Level 5 , Pharmaceuticals Amp Medical Research Trbc Level 2 , Science Technology , Reuters Top News , ஒன்றுபட்டது மாநிலங்களில் , கரோலின் கப்பலே , ஜான் மில்லர் , ஹக் லாசன் , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ப்ரிந்ஸிபல்ஸ் , பல்கலைக்கழகம் ஆஃப் பென்சில்வேனியா , தெற்கு சான் பிரான்சிஸ்கோ ,

Valneva's COVID-19 shot set for Phase Three trial this month

By Reuters Staff
2 Min Read
PARIS (Reuters) -Valneva on Tuesday reported positive results for its COVID-19 vaccine in early stage clinical trials and said it planned to launch a Phase Three trial this month.
FILE PHOTO: A woman holds a small bottle labelled with a Coronavirus COVID-19 Vaccine sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic
The French drugmaker, whose shot uses the technology behind its licensed Japanese encephalitis vaccine, tested its vaccine in 153 adults with three dose levels based on a schedule of two doses with vaccinations three weeks apart.
Valneva shares were up 8% in early trading. ....

France General , United Kingdom , Matthias Blamont , Jason Neely , Kirsten Donovan , Thomson Reuters Trust Principles , European Union , Phase Three , Data Safety Monitoring , Thomson Reuters Trust , Corona Virus , Drug Amp Device Development , General News , Health Medicine , Healthcare Trbc Level 1 , Volatile Shares Hot Stocks , Medical Regulation , Major News , Pharmaceuticals Amp Medical Research Trbc Level 2 , Respiratory Conditions , Western Europe , பிரான்ஸ் ஜநரல் , ஒன்றுபட்டது கிஂக்டம் , ஜேசன் நீலீ , கர்ஸ்டந் டொநொவந் , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ப்ரிந்ஸிபல்ஸ் ,

EU drug regulator investigating 62 reports of rare clotting worldwide: chief

By Reuters Staff
1 Min Read
LONDON (Reuters) - Europe’s drug regulator is investigating 62 cases worldwide of a rare blood clotting condition which has prompted some countries to limit the use of AstraZeneca’s COVID-19 vaccine, its chief Emer Cooke said in a briefing on Wednesday.
That includes 44 cases in the European Economic Area out of a total of 9.2 million people who have received the vaccine in the region, she said.
The total cited by the European Medicines Agency (EMA) does not include all the cases of the condition, known as cerebral venous sinus thrombosis (CVST), which have been reported in Germany, she said. ....

City Of , United Kingdom , Gareth Jones , Josephine Mason , Ludwig Burger , Pushkala Aripaka , Emer Cooke , Thomson Reuters Trust Principles , European Medicines Agency , European Economic Area , Thomson Reuters Trust , Corona Virus , Asia Pacific , Company News , Drug Amp Device Development , Drug Safety , Haematology Blood Disorders , Health Medicine , Healthcare Trbc Level 1 , South America Central , Medical Regulation , Pharmaceuticals Nec Trbc Level 5 , Pharmaceuticals Amp Medical Research Trbc Level 2 , Corporate Market Regulation , Science Technology , Reuters Top News ,

CanSinoBIO says COVID-19 shot may be less effective over time, booster shot promising

By Reuters Staff
2 Min Read
FILE PHOTO: A logo of China s vaccine specialist CanSino Biologics Inc is pictured on the company s headquarters in Tianjin, following an outbreak of the coronavirus disease (COVID-19), China August 17, 2020. REUTERS/Thomas Peter
BEIJING (Reuters) - China’s CanSino Biologics Inc said the efficacy rate for its single-dose COVID-19 vaccine may fall over time although it should still have a rate of 50% or more five to six months after inoculation.
A second shot given to trial participants six months after their first injection could offer substantial protection, Zhu Tao, CanSinoBIO’s chief scientific officer, said in an online presentation late on Wednesday. ....

Tony Munroe , Roxanne Liu , Zhu Tao , Miyoung Kim , Edwina Gibbs , Thomson Reuters Trust Principles , China Cansino Biologics Inc , Cansino Biologics Inc , Thomson Reuters Trust , Corona Virus , Cansino Bio , Asia Pacific , Company News , China Prc , Drug Amp Device Development , Emerging Market Countries , Health Medicine , Healthcare Trbc Level 1 , Hong Kong , South America Central , Medical Regulation , Major News , Pharmaceuticals Amp Medical Research Trbc Level 2 , Reuters Top News , டோனி மன்ரோ , ரோக்ஷ்ண்னே லியூ ,

EU countries agree to share 'solidarity vaccines' with states in need

By Reuters Staff
3 Min Read
BRUSSELS (Reuters) - Most European Union member states on Thursday agreed to share part of their upcoming vaccine deliveries with the five EU countries they said need them most.
FILE PHOTO: Vials with Pfizer-BioNTech, AstraZeneca, and Moderna coronavirus disease (COVID-19) vaccine labels are seen in front of a European Union (EU) flag in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
The EU’s vaccine doses are usually distributed between the bloc’s 27 countries based on population size.
After days of negotiations, EU ambassadors on Thursday agreed to change that system for 10 million BioNTech-Pfizer doses due to be delivered in the second quarter, so needier countries received more. ....

Czech Republic , Bruxelles Capitale , Kate Abnett , Alistair Bell , Andrej Plenkovic , Kaja Kallas , Gabriela Baczynska , Thomson Reuters Trust Principles , Most European Union , European Union , Prime Minister Andrej Plenkovic , Prime Minister Kaja Kallas , Thomson Reuters Trust , Corona Virus , Drug Amp Device Development , East European Countries , Healthcare Policy , Healthcare Trbc Level 1 , Industrials Trbc Level 1 , Biotechnology Amp Medical Research Trbc Level 4 , Nordic States , Pharmaceuticals Amp Medical Research Trbc Level 2 , Public Health , International Trade , செக் குடியரசு , ப்ரூக்ஸெல்ஸ் தலைநகரம் ,